09/08/10 -- Peregrine Pharmaceuticals, Inc. (PPHM), a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, today announced it will present at the Rodman & Renshaw 12th Annual Healthcare Conference on Monday, September 13, 2010 at 4:30 pm EDT.
09/07/10 -- Peregrine Pharmaceuticals, Inc. (PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced the issuance of two U.S. patents providing protection for tumor vasculature imaging and antiviral applications of a broad range of phospholipid-targeting antibodies.
09/02/10 -- Peregrine Pharmaceuticals, Inc. (PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced that it will report financial results for the first quarter fiscal year 2011 on September 9, 2010 after market and will host a conference call and webcast at 4:30 p.m. EDT.
* Q4 loss/shr $0.16 vs est loss/shr $0.09. * Q4 revenue $4.4 mln vs est $6.8 mln. * Shares down 14 pct in after-market trade. Peregrine Pharmaceuticals Inc (PPHM) posted a wider-than-expected quarterly loss, hurt by a drop in revenue from contract manufacturing and government contracts, sending its shares down as much as 14 percent in after-market trade.
Events
Sep
9
PPHM to announce Q1 earnings After Market (Confirmed)
Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and manufacture of monoclonal antibodies for the treatment of cancer and viral infections.
Environmental, Social & Governance Summary (ESG)
ESG ratings enable you to leverage independent ESG research to evaluate how companies are managing ESG risks and addressing ESG opportunities. Log in for more information
About Environmental, Social & Governance Summary (ESG)
The RiskMetrics ESG Composite Rating is a measure of how well a company manages ESG risks and addresses ESG opportunities. If a company is performing adequately on this measure, it receives a Yellow rating. If it is more effective, it receives a Green rating. If the company is not managing ESG risks and opportunities effectively, it receives a Red rating. The ESG Composite Rating is provided for the largest 3,000 U.S companies by market capitalization.
About RiskMetrics Group, Inc.
RiskMetrics Group, Inc. provides risk management tools, corporate governance products and services, and financial research and analysis for investors. By bringing transparency, expertise and access to the financial markets, RiskMetrics Group helps investors better understand and manage the risk and opportunity profiles of their portfolios. RiskMetrics Group is headquartered in New York, with 20 global offices.
A RiskMetrics Vice Alert is triggered when a company derives at least 15% of
its revenue from adult entertainment, alcohol, gambling, and/or tobacco.
RiskMetrics Group, Inc. ensures the accuracy of company information with frequent
updates using data from public documents, non-governmental agencies,
government agencies, press searches, trade journals, industry and
regional publications, and direct contact with companies. Rigorous
internal quality assurance and editing processes ensure consistent
coverage across all publicly traded companies and issues.
About RiskMetrics Group, Inc.
RiskMetrics Group, Inc. provides risk management tools, corporate governance products and services, and financial research and analysis for investors. By bringing transparency, expertise and access to the financial markets, RiskMetrics Group helps investors better understand and manage the risk and opportunity profiles of their portfolios. RiskMetrics Group is headquartered in New York, with 20 global offices.
Audit Integrity Accounting and Governance Risk (AGR®) Score & Rating
The Audit Integrity Accounting and Governance Risk
(AGR®) Score & Rating is widely recognized as an
indicator of the confidence level surrounding a company's management and
reported financials.
Scores range from 0 to 100, and correspond to a risk classification
for each company ranging from "Very Aggressive" to "Conservative."
The AGR Score is a percentile ranking among the approximately 8.000 companies rated by Audit Integrity.
Through continued back-testing, Audit Integrity has demonstrated a
strong correlation between its quarterly AGR® Score and the likelihood of
adverse events, including securities class action litigation, financial
restatements, regulatory enforcement actions, and stock price declines.
Thus, a company's AGR® Score can help investors looking to manage risk or
enhance investment performance. Audit Integrity forensically analyzes
the financial reporting and governance practices of over 8,000 North
American-based publicly traded companies.
About Audit Integrity, Inc.
Audit Integrity is an independent risk research firm which provides a
statistically modeled assessment of corporate integrity. Founded in 2002
in direct response to the growing number of scandals, lawsuits and
investor losses resulting from fraudulent corporate behavior, the firm
identifies potential high-risk company accounting and governance
activity, which in turn has been historically correlated to stock price
declines, securities class-action litigation, and material financial
restatements. The product of Audit Integrity's analysis is a unique risk
measure - the AGR® Score which can be used by investors
as a way to more effectively manage corporate risk.
A compilation of independent third-party news and information that highlights key fundamental and technical data, analyst opinions, last 90-days of significant news, stock price movement, earnings data and industry comparison. Available only for Fidelity customers.